By Zachary Blaisdell Care Coordination Manager, PharmCare Services

The Hidden Crisis for Expatriate Employees

For multinational companies and leaders of global commerce, the world is their workplace. As your company expands its global footprint, your human resources and benefits teams face an obstacle that is often overlooked but profoundly impacts the health and productivity of your most valuable assets: your international employees. While global commerce is complicated, global healthcare—especially the management of specialty medications—is even more so.

Imagine a valued team member, essential to an overseas project, who manages a chronic, complex condition such as rheumatoid arthritis, multiple sclerosis, or a complex cancer. These conditions often require specialty medications—high-cost, complex drugs that typically demand special handling, administration, and ongoing clinical support.

For too long, the accepted reality was that an employee requiring such treatment had only one viable option: frequent, disruptive travel back to the United States every one to three months just to fill or receive their life-saving or life-sustaining prescription. This process is not only incredibly costly in terms of travel and lost productivity, but it also places a significant, constant burden on the employee’s physical and mental well-being, compounding the stress of managing a serious illness in a foreign country.

This simply is not a sustainable model for a healthy, secure, and productive global workforce. Quality healthcare shouldn’t stop at the border.

Introducing International Pharmaceutical Management (IPM)

At PharmCare Services, we recognized this critical gap and developed an innovative, clinical-first solution to eliminate the need for recurrent “medication tourism.” We call this specialized service International Pharmaceutical Management (IPM).

The mission of IPM is simple: We oversee the provision of medications, particularly specialty medications, worldwide, with a commitment to safety and integrity.

As a multinational team of doctors, nurses, pharmacists, and business professionals, we manage both the essential clinical support and the complex logistics of specialty drug distribution abroad.

Our Clinical Foundation: Comprehensive Care

Our service is built on a robust clinical foundation that ensures continuity of care, safety, and adherence for your employees, no matter their location. We handle the intricacies that go far beyond simple fulfillment:

• Prescription Verification: Ensuring prescriptions meet international standards and local requirements.
• Patient Follow-up: Providing ongoing support and education to maximize adherence and manage side effects.
• Provider Consultation: Communicating directly with US and foreign providers to coordinate care and manage therapy changes.
• Insurance Communication: Streamlining the complex process of benefit verification and prior authorizations for high-cost treatments.
• Pharmacovigilance: Implementing systematic processes for monitoring the safety of medicines along their journey to patient use.

This clinical oversight is seamlessly integrated with the necessary supply chain management, which requires navigating an intricate web of international regulations, customs clearance, and specialized transport. Specialty pharmaceuticals often require cold-chain logistics to ensure their efficacy is maintained upon arrival. We’ve become experts in handling this entire, end-to-end process.

We handle these complex cases on a daily basis and have built a robust infrastructure with physical locations in the United States, Latin America, and Europe, giving us access to a network of over 65,000 pharmacies worldwide.

Conclusion: Health, Security, and Global Productivity

The challenge of providing specialty medications to American employees abroad is no longer an unsolvable logistical hurdle. For multinational corporations, ensuring that a serious illness doesn’t also mean a serious disruption to an employee’s life—or to the company’s operations—is a crucial element of a modern benefits package.

Through our International Pharmaceutical Management (IPM) service, PharmCare Services delivers a comprehensive, clinical-first solution. We replace the stress and expense of frequent international travel with a system built on expert clinical management—from prescription verification and provider consultation to ongoing patient follow-up and pharmacovigilance—all backed by our global network and specialized logistics expertise.

Our mission is to make life easier for you and, most importantly, for your employees who are working hard for you abroad. By providing this essential support, we help ensure your international workforce is healthy, secure, and can focus on their jobs without the added stress of managing their medication from thousands of miles away.

At PharmCare Services, we are your dedicated partner in global health and wellness. Let us help you take care of your people, wherever they are, and realize the true potential of your global team.

By Dr. Raciel Rizo, MD, Regional Medical Director, Latin America, PharmCare Services

When it comes to healthcare in Latin America, the conversation often revolves around access, infrastructure, and cost—but few recognize the intricate challenge that lies at the core of ongoing care management: pharmacotherapy. As the Medical Director overseeing several nations in this part of the world, I’ve seen firsthand how medication management—seemingly straightforward in well-integrated health systems—becomes a puzzle of logistical, regulatory, and clinical complexity across borders.

Disparities Between Knowledge and Practice

Physicians throughout Latin America are highly motivated and increasingly well-informed. Many attend global medical conferences, complete continuing education, and stay current with the latest treatment guidelines. In theory, our clinicians are ready to offer best-in-class care. In practice, however, they are often constrained by the realities on the ground.

A doctor in Argentina may want to prescribe a cutting-edge biologic for a patient with rheumatoid arthritis—yet that medication may not be registered locally, or worse, it’s approved but entirely unavailable due to market withdrawals or pricing issues. A physician in Paraguay may understand the ideal GLP-1 agonist for a patient with obesity and metabolic syndrome but lack the ability to source it reliably, making adherence and therapeutic success nearly impossible.

Regional Barriers: From Infrastructure to Regulation

Latin American countries operate under varying regulatory frameworks, pricing controls, reimbursement structures, and distribution systems. This mosaic leads to unequal access to medications that are standard of care elsewhere. The result? Clinicians are left improvising, modifying treatment plans to fit what’s accessible—not what’s optimal.

To complicate matters further, there’s a lack of harmonization in how medications are handled across borders. Cold chain requirements, specialty handling needs, and controlled substance regulations all add friction that few insurers or policymakers see, but all prescribers feel.

For international payers and TPAs (Third-Party Administrators), these issues can lead to claim delays, prior authorization conflicts, and unexpected cost escalations—simply because the reality on the ground diverges so widely from what clinical guidelines and policy documents assume.

Bridging the Gap with Collaborative Expertise

This is where strategic collaboration becomes not just helpful, but essential.

At PharmCare Services, we’ve developed a model that supports physicians with cross-border expertise and real-world logistics. Our team includes physicians, pharmacists, and operational experts from multiple countries and specialties who work together to align the clinical ideal with what is feasible in each market. To enhance our efforts, we’ve also established a state-of-the-art international pharmaceutical management (IPM) platform, PCSRx.

This platform serves as a critical extension of our team’s work, helping to facilitate our services by connecting patients, prescribers, and payers in real time. It enables our experts to more efficiently access the information needed to navigate complex challenges. We don’t simply look at a prescription as a “yes or no” choice; we use the platform to help identify therapeutic alternatives when a first-line agent is unavailable, navigate regulatory pathways to dispense critical therapies when needed, and ensure cold-chain integrity and pharmacovigilance protocols are followed.

By leveraging our team’s expertise and the supportive functions of the PCSRx platform, we relieve a major burden from both physicians and insurers, allowing them to focus on care instead of procurement, as well as avoid unnecessary costs, misaligned approvals, or treatment abandonment due to medication unavailability.

A Call for Alignment

If there is one message I would deliver to the international private insurance community, it’s this: managing specialty pharmacotherapy in Latin America is not just about approving the right drugs—it’s about understanding the real-world limitations in distributing, dispensing, and maintaining those therapies across fragmented systems.

The solution is not always tighter policy—it’s closer cooperation with those who understand the clinical and logistical terrain.

With coordinated efforts between prescribers, PharmCare Services’ multi-national clinical team, and international payers, we can transform pharmacotherapy from a pain point into a point of partnership—improving outcomes for patients and reducing inefficiencies for payers alike.

About the Author

Dr. Raciel Rizo, MD, serves as the Regional Medical Director for PharmCare Services within Latin America, where he oversees cross-border clinical operations and care strategy. With over 20 years of experience in internal medicine and health system leadership, Dr. Rizo is committed to advancing equitable access to therapies across Latin America.